CClinicalTrials.gg
CompletedNCT02885415POMYUpdated Sep 26, 2017

Prevalence of Myocardial Injury in Gastrointestinal Surgery Patients

An observational study in Myocardial Injury, sponsored by National University of Ireland, Galway, Ireland. Completed at 4 sites in Ireland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-26.

Sponsored by National University of Ireland, Galway, Ireland · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
101
Ages
18 Years and older
Sex
All
01

Study summary

the troponin level and ECGs pre and post operative will be used to determined prevalence of myocardial injury among patients undergoing gastrointestinal surgery

Read the detailed description

AIM:

The aim of this study is to determine the prevalence of myocardial injury in gastrointestinal surgery patients and to establish baseline data to allow evaluation of the potential benefit of RIPC (remote ischemic preconditioning) in these patients

Significance:

In available literature was one study including 51 patients that focused on postoperative arrhythmias in colorectal surgery . We think this study is important to establish more specifically the prevalence of myocardial injury in this cohort of patients so we can measure in our future research if RIPC or any other protective method could produce significant effect.

Study Design:

Prospective Observational cohort Study

Study Objectives:

To determine the prevalence of myocardial injury in patients undergoing gastrointestinal surgery

Patients and Locations:

Patients older than 18 years undergoing major resectional gastrointestinal surgery in Galway University Hospitals (UCHG, Mayo university Hospital), The Midland Regional Hospital, Tullamore and Letterkenny University Hospital will be asked to join the study and will considered eligible after informed consent and information handouts provided.

Protocol:

After informed consent patients' pre-op demographic data, co-morbidities, bloods including troponin and ECG will be recorded. Serum troponin levels will be measured daily for the first 72 hours and a 12-lead electrocardiogram will be performed at 48 hours post-surgery. There will be 1 year flow up for candidates

Data Handling:

The data for each hospital will be kept locally and patients will be allocated numbers for later data analysis. The pooled data will be analyzed using a secure computer in an NUI Galway research facility building. No patients' name or any other identifier will be associated with this data except for their study number assigned earlier

Primary Outcome:

Prevalence of myocardial injury by comparing pre and post-op troponin and ECGs. The diagnosis of myocardial injury will be determined by a cardiologist after examining troponin and ECGs results using SAVES trial criteria (5).

Perioperative Myocardial injury will include silent myocardial infarctions as determined by the study cardiologist upon examination of study ECGs and troponin results. The diagnosis of a myocardial injury will require the presence of at least two of the following:

  1. Characteristic ischemic symptoms lasting at least 20 minutes
  2. Electrocardiographic changes including acute ST elevation followed by the appearance of Q waves or the loss of R waves, the development of new left bundle branch block, new persistent T wave inversion lasting at least 24 hours or new ST segment depression persisting over 24 hours
  3. Positive troponin above normal range (0-14)
  4. New-onset arrhythmia (ventricular or supraventricular tachycardia or fibrillation) with an associated rise in troponin levels
  5. Alternatively, myocardial injury will be recorded if the patient develops sudden unexpected cardiac death involving cardiac arrest with symptoms suggestive of myocardial ischemia and accompanied by presumably new ST elevation or new left bundle branch block and/or fresh thrombus on coronary angiography and/or at post-mortem, but death occurring before blood samples could be obtained or at a time before the appearance of cardiac troponin I or T in the blood.

Other Data:

  • Age
  • Gender
  • Procedure type
  • Renal Profile (Renal impairment will be consider when interpreting Troponin values)
  • ECG
  • Ethnicity
  • Diabetes
  • BP
  • History of Cardiac event
  • Other Comorbidities
  • Smoking history
  • NYHA classification (New York Heart Association )
  • Medication at time of consent (Blood pressure and heart rate control medications)

Exclusion Criteria

  • Documented Pre-op Myocardium Injury
  • Refused or unable to give informed consent
  • Laparoscopic fundoplication
  • Laparoscopic cholecystectomy surgery
  • Appendectomy surgery
  • Hernia repair surgery

Sample Size:

This is a prospective study to determine the incidence of myocardial injury in gastrointestinal surgical patients. There are no existing data upon which to base a sample size calculation. We estimate that data from 100 patients should provide a sufficient sample size to generate a reasonably robust incidence estimate. However, if the included centers recruit more patients they will be included in our analysis

Statistical Analysis:

Statsdirect will be used for analysis of the study results Budget No additional budget for the study will be needed as tests required routinely requested within the study clinical setting. The analysis and management of the study will be performed by clinical research fellow funded by National University of Ireland Galway

Conflict of interest:

Study team declare no conflict of interest

02

Conditions studied

  • Myocardial Injury

Browse trials for

03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

This study's enrollment of 101 is below the median of 135 across 1,597 observational studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

National University of Ireland, Galway, Ireland is the lead sponsor of 46 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients older than 18 years undergoing major resectional gastrointestinal surgery in Galway University Hospitals (UCHG, Mayo university Hospital), The Midland Regional Hospital, Tullamore and Letterkenny University Hospital will be asked to join the study and will considered eligible after informed consent and information handouts provided.

Inclusion criteria

  • Patients older than 18 years undergoing major resectional gastrointestinal surgery (define as resection of part of gastrointestinal tract ( oesophageal, Gastric or colorectal surgeries)

Exclusion criteria

Exclusion Criteria:

    • Documented Pre-op Myocardium Injury
  • Refused or unable to give informed consent
  • Laparoscopic fundoplication
  • Laparoscopic cholecystectomy surgery
  • Appendectomy surgery
  • Hernia repair surgery
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
101 participants (actual)
Patient registry
No

Interventions

  • ProcedureGastrointestinal surgery

    Major resectional gastrointestinal surgery (define as resection of part of gastrointestinal tract during esophageal, Gastric or colorectal surgeries)

06

What researchers measure

Primary outcomes

  1. Change in Troponin

    Cahnges in Troponin levels Pre-Op and Day 1, Day 2 and Day 3 post-OP

    Time frame: Pre-Op and 3 days series post-op results

  2. ECG changes

    Changes as per Protocol Criteria

    Time frame: Pre-Op and 48 hours post-op

07

Study locations

4 sites
  • University Collage Hospital Galway
    Galway, Co Galway, Ireland
  • Letterkenny University Hospital
    Letterkenny, Donegal, Ireland
  • Mayo University Hospital
    Castlebar, Mayo, Ireland
  • Midland Regional Hospital, Tullamore
    Tullamore, Ireland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02885415
Lead sponsor
National University of Ireland, Galway, Ireland
Collaborators
Midland Regional Hospital, Tullamore, Mayo University Hospital, Letterkenny University Hospital, University College Hospital Galway
Responsible party
KHALID AHMED (Mr, National University of Ireland, Galway, Ireland) — Principal investigator
First posted
Aug 31, 2016
Start date
Aug 2016
Primary completion
Aug 5, 2017
Completion
Sep 5, 2017
Last update
Sep 26, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion